Xu Y - Search Results

1

Cistrome analysis of YY1 uncovers a regulatory axis of YY1:BRD2/4-PFKP during tumorigenesis of advanced prostate cancer.

Xu C, Tsai YH, Galbo PM, Gong W, Storey AJ, Xu Y, Byrum SD, Xu L, Whang YE, Parker JS, Mackintosh SG, Edmondson RD, Tackett AJ, Huang J, Zheng D, Earp HS, Wang GG, Cai L. Xu C, et al. Among authors: xu l, xu y. Nucleic Acids Res. 2021 May 21;49(9):4971-4988. doi: 10.1093/nar/gkab252. Nucleic Acids Res. 2021. PMID: 33849067 Free PMC article.

2

Anti-Warburg effect by targeting HRD1-PFKP pathway may inhibit breast cancer progression.

Fan Y, Wang J, Xu Y, Wang Y, Song T, Liang X, Jin F, Su D. Fan Y, et al. Among authors: xu y. Cell Commun Signal. 2021 Feb 15;19(1):18. doi: 10.1186/s12964-020-00679-7. Cell Commun Signal. 2021. PMID: 33588886 Free PMC article.

3

Inhibition of p22^phox Suppresses Epithelial Ovarian Cancer Cell Proliferation and Tumorigenesis.

Li Q, Feng X, Niu F, Yang J, Xu Y, Pu X, Chen J, Fan X, Jiang B, Huang Q. Li Q, et al. Among authors: xu y. J Cancer. 2021 May 19;12(14):4277-4287. doi: 10.7150/jca.54163. eCollection 2021. J Cancer. 2021. PMID: 34093828 Free PMC article.

4

CircNR3C2 promotes HRD1-mediated tumor-suppressive effect via sponging miR-513a-3p in triple-negative breast cancer.

Fan Y, Wang J, Jin W, Sun Y, Xu Y, Wang Y, Liang X, Su D. Fan Y, et al. Among authors: xu y. Mol Cancer. 2021 Feb 2;20(1):25. doi: 10.1186/s12943-021-01321-x. Mol Cancer. 2021. PMID: 33530981 Free PMC article.

5

Twist1 in podocytes ameliorates podocyte injury and proteinuria by limiting CCL2-dependent macrophage infiltration.

Ren J, Xu Y, Lu X, Wang L, Ide S, Hall G, Souma T, Privratsky JR, Spurney RF, Crowley SD. Ren J, et al. Among authors: xu y. JCI Insight. 2021 Aug 9;6(15):e148109. doi: 10.1172/jci.insight.148109. JCI Insight. 2021. PMID: 34369383 Free PMC article.

6

HRD1 suppresses the growth and metastasis of breast cancer cells by promoting IGF-1R degradation.

Xu YM, Wang HJ, Chen F, Guo WH, Wang YY, Li HY, Tang JH, Ding Y, Shen YC, Li M, Xuan WY, Liu LH, Wang J, Wang XR, Gao ZJ, Liang XB, Su DM. Xu YM, et al. Oncotarget. 2015 Dec 15;6(40):42854-67. doi: 10.18632/oncotarget.5733. Oncotarget. 2015. PMID: 26536657 Free PMC article.

7

Clinicopathological features to distinguish malignant solitary fibrous tumors of the prostate from prostatic stromal tumors.

Xu Y, Li Z, Shi J, Fu Y, Zhu L, Fan X, Foo WC. Xu Y, et al. Virchows Arch. 2021 Apr;478(4):619-626. doi: 10.1007/s00428-020-02909-2. Epub 2020 Aug 20. Virchows Arch. 2021. PMID: 32820389

8

Malignant Gastrointestinal Neuroectodermal Tumor in the Right Heart: A Report of an Extremely Rare Case Presenting With a Cardiac Mass.

Li Z, Pu X, He L, Fu Y, Li L, Xu Y, Guan W, Fan X. Li Z, et al. Among authors: xu y. Front Cardiovasc Med. 2021 Sep 1;8:702215. doi: 10.3389/fcvm.2021.702215. eCollection 2021. Front Cardiovasc Med. 2021. PMID: 34540914 Free PMC article.

9

Correction to: Anti-Warburg effect by targeting HRD1-PFKP pathway may inhibit breast cancer progression.

Fan Y, Wang J, Xu Y, Wang Y, Song T, Liang X, Jin F, Su D. Fan Y, et al. Among authors: xu y. Cell Commun Signal. 2021 Nov 15;19(1):111. doi: 10.1186/s12964-021-00803-1. Cell Commun Signal. 2021. PMID: 34781962 Free PMC article. No abstract available.

10

Deep learning segmentation of glomeruli on kidney donor frozen sections.

Li X, Davis RC, Xu Y, Wang Z, Souma N, Sotolongo G, Bell J, Ellis M, Howell D, Shen X, Lafata KJ, Barisoni L. Li X, et al. Among authors: xu y. J Med Imaging (Bellingham). 2021 Nov;8(6):067501. doi: 10.1117/1.JMI.8.6.067501. Epub 2021 Dec 20. J Med Imaging (Bellingham). 2021. PMID: 34950750 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

67,462 results

Search Page